论文部分内容阅读
１目的探讨肺栓塞溶栓治疗后颅内出血发生情况及相关危险因素。２方法回顾性地选取经肺血管造影等确诊的３７３例肺栓塞患者,根据其治疗方案,进行分组对比研究:①４７例应用重组组织纤溶酶原激活剂（ｒｔ-ＰＡ）５０～９０ｍｇ／２～６ｈ;②４５例随机应用ｒｔ-ＰＡ１００ｍｇ
1 Objective To investigate the incidence of intracranial hemorrhage after thrombolysis in pulmonary embolism and related risk factors. 2 Methods Retrospectively selected 373 cases of pulmonary embolism diagnosed by pulmonary angiography, according to the treatment plan, the group compared the study: ①47 cases of recombinant tissue plasminogen activator (rt-PA) 50 ~ 90mg / 2 ~ 6h; ② 45 cases randomized rt-PA100mg